0.68 - 0.75
0.33 - 0.86
18.36M / 4.66M (Avg.)
34.50 | 0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
5.54%
Revenue growth at 50-75% of 3606.HK's 7.59%. Martin Whitman would worry about competitiveness or product relevance.
-15.02%
Negative gross profit growth while 3606.HK is at 2.08%. Joel Greenblatt would examine cost competitiveness or demand decline.
-30.53%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-30.53%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
2.50%
Net income growth above 1.5x 3606.HK's 0.06%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
0.99%
EPS growth of 0.99% while 3606.HK is zero. Bruce Berkowitz would see if minimal gains can accelerate over time.
-4.19%
Negative diluted EPS growth while 3606.HK is at 0.00%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
1.44%
Share change of 1.44% while 3606.HK is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
7.00%
Diluted share change of 7.00% while 3606.HK is zero. Bruce Berkowitz might see a minor difference that could widen over time.
No Data
No Data available this quarter, please select a different quarter.
39.94%
Positive OCF growth while 3606.HK is negative. John Neff would see this as a clear operational advantage vs. the competitor.
37.76%
Positive FCF growth while 3606.HK is negative. John Neff would see a strong competitive edge in net cash generation.
247.66%
10Y revenue/share CAGR 1.25-1.5x 3606.HK's 209.93%. Bruce Berkowitz would investigate brand strength or geographical expansion fueling growth.
19.94%
5Y revenue/share CAGR at 50-75% of 3606.HK's 36.40%. Martin Whitman would worry about a lagging mid-term growth trajectory.
-10.19%
Negative 3Y CAGR while 3606.HK stands at 9.56%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-6520.63%
Negative 10Y OCF/share CAGR while 3606.HK stands at 80.38%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-394.38%
Negative 5Y OCF/share CAGR while 3606.HK is at 0.00%. Joel Greenblatt would question the firm’s operational model or cost structure.
-261.16%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
17.38%
Below 50% of 3606.HK's 116.59%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
27.23%
5Y net income/share CAGR at 50-75% of 3606.HK's 41.82%. Martin Whitman might see a shortfall in operational efficiency or brand power.
59.09%
Positive short-term CAGR while 3606.HK is negative. John Neff would see a clear advantage in near-term profit trajectory.
No Data
No Data available this quarter, please select a different quarter.
97.28%
5Y equity/share CAGR at 75-90% of 3606.HK's 123.74%. Bill Ackman might push for an improved ROE or share repurchase strategy to keep up.
6.65%
Below 50% of 3606.HK's 75.82%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
578.71%
Below 50% of 3606.HK's 2136.09%. Michael Burry worries the firm returns far less capital to shareholders over 5 years.
120.50%
3Y dividend/share CAGR above 1.5x 3606.HK's 44.75%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
44.39%
AR growth well above 3606.HK's 6.95%. Michael Burry fears inflated revenue or higher default risk in the near future.
-44.69%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
14.57%
Asset growth above 1.5x 3606.HK's 0.91%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
2.88%
Positive BV/share change while 3606.HK is negative. John Neff sees a clear edge over a competitor losing equity.
206.46%
Debt growth far above 3606.HK's 31.56%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
-36.19%
Our R&D shrinks while 3606.HK invests at 0.00%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-4.02%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.